Drug comparisons
Linagliptin vs Nateglinide
Compare Linagliptin (Tradjenta) and Nateglinide for type 2 diabetes. DPP-4 vs meglitinide: A1C efficacy, hypoglycemia risk, and mealtime dosing.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when adding an oral agent for type 2 diabetes, choosing between overall glycemic control and postprandial targeting.
Bottom line
Linagliptin is often preferred for convenience and safety, while nateglinide suits mealtime glucose control needs.
All medication comparisons